Bosh sahifa069620 ā¢ KRX
add
Daewoong Pharma
Yopilish kursi
133Ā 800,00Ā ā©
Kunlik diapazon
130Ā 900,00Ā ā© - 134Ā 400,00Ā ā©
Yillik diapazon
100Ā 100,00Ā ā© - 164Ā 400,00Ā ā©
Bozor kapitalizatsiyasi
1,53Ā trln KRW
OŹ»rtacha hajm
28,59Ā ming
Narx/foyda
14,63
Dividend daromadliligi
-
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 358,47Ā mlrd | 5,16% |
Joriy xarajat | 144,74Ā mlrd | 7,00% |
Sof foyda | 28,28Ā mlrd | 81,53% |
Sof foyda marjasi | 7,89 | 72,65% |
Har bir ulushga tushum | ā | ā |
EBITDA | 49,20Ā mlrd | 21,91% |
Amaldagi soliq stavkasi | -3,14% | ā |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 107,51Ā mlrd | -37,49% |
Jami aktivlari | 1,92Ā trln | 12,48% |
Jami passivlari | 971,10Ā mlrd | 13,73% |
Umumiy kapital | 951,35Ā mlrd | ā |
Tarqatilgan aksiyalar | 11,51Ā mln | ā |
Narxi/balansdagi bahosi | 1,88 | ā |
Aktivlardan daromad | 4,90% | ā |
Kapitaldan daromad | 6,10% | ā |
Pul aylanmasi
Naqd pulning sof oŹ»zgarishi
| (KRW) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 28,28Ā mlrd | 81,53% |
Operatsiyalardan naqd pul | 22,21Ā mlrd | -65,56% |
Sarmoyadan naqd pul | -51,68Ā mlrd | -61,59% |
Moliyadan naqd pul | 36,58Ā mlrd | 3Ā 410,29% |
Naqd pulning sof oŹ»zgarishi | 6,89Ā mlrd | -77,97% |
BoŹ»sh pul | -35,44Ā mlrd | -283,86% |
Haqida
Daewoong Pharmaceutical Co., Ltd. is a pharmaceutical company headquartered in Seoul, South Korea. Daewoong Pharmaceutical primarily engages in the manufacture of pharmaceutical products, including prescription and over-the-counter healthcare products. Wikipedia
Tashkil etilgan
1945
Sayt
Xodimlar soni
1Ā 727
